French Guiana Wellness Network: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on French Guiana Wellness Network.

Press releases published on September 23, 2026

Sep. 23, 2026

Virtuix Expands Autism Therapy Program with New Partner and Multi-Site Pilot Beginning January 2027

Indeterminate GlobeNewswire

Sep. 23, 2026

Retinal Photocoagulation Laser Market Trends And Forecast Analysis Reveal Strong Long-Term Potential

Indeterminate EIN Presswire

Sep. 23, 2026

BioCardia Confirms Timing and Provides Update on FDA Helix Pre-Submission and PMDA CardiAMP HF Shonin Submission

Indeterminate GlobeNewswire

Sep. 23, 2026

Retinal Dystrophy Treatment Market By The Business Research Company, Highlights Future Industry Trends, Forecasts

Indeterminate EIN Presswire

Sep. 23, 2026

Bionano Laboratories Announces Expansion of Diagnostic Testing Based on Optical Genome Mapping for Hematologic Malignancies

Indeterminate GlobeNewswire

Sep. 23, 2026

Pycnogenol® Offers Clinically Backed Cognitive Support Across Generations

Indeterminate GlobeNewswire

Sep. 23, 2026

IRADIMED CORPORATION To Participate in the 5th Annual ROTH Healthcare Opportunities Conference

Indeterminate GlobeNewswire

Sep. 23, 2026

Retail Pharmacy Market Report Examines Market Dynamics, Segment Insights And Company Strategies

Indeterminate EIN Presswire

Sep. 23, 2026

Palisade Bio Expands Global Phase 2b ASCENTRA-UC Program with Health Canada CTA Clearance

Indeterminate GlobeNewswire

Sep. 23, 2026

SciSparc: Subsidiary NeuroThera Highlights Enhancement of U.S. Patent Portfolio Through Collaboration with Clearmind Covering LSD, Ketamine and Ibogaine Combinations

Indeterminate GlobeNewswire

Sep. 23, 2026

Parexel Transforms Functional Service Provider (FSP) Model to Improve R&D Productivity and Enhance Post-Approval Product Lifecycle Services for Biopharmaceutical Companies

Indeterminate GlobeNewswire

Sep. 23, 2026

Actinogen XanaMIA pivotal Alzheimer’s disease trial completes final patient visit, with topline results on track for November

Indeterminate GlobeNewswire

Sep. 23, 2026

Moleculin Biotech Secures Mexican Patent Protecting Lung-Targeted Liposomal Annamycin Through 2040

Indeterminate GlobeNewswire

Sep. 23, 2026

MaxCyte Appoints Sidharth Kapileshwar as Chief Corporate Development Officer

Indeterminate GlobeNewswire

Sep. 23, 2026

Monogram Health Appoints James Lim as Chief Technology Officer

Indeterminate GlobeNewswire

Sep. 23, 2026

Restriction Enzyme Market Forecast Report Featuring Segment Analysis And Strategic Industry Insight

Indeterminate EIN Presswire

Sep. 23, 2026

ProQR Announces Appointment of Chris Hart as Chief Data and AI Officer and Thomas Wolf to join the Board of Directors as Strategic AI Advisor

Indeterminate GlobeNewswire

Sep. 23, 2026

SOTIO Advances SOT106 with Dual FDA Designations, Further Positioning the Program as a Potential Best-in-Class ADC for Sarcoma

Indeterminate GlobeNewswire

Sep. 23, 2026

Annovis Announces Partnership with Weave Bio, AI Regulatory Platform, in Preparation of NDA for Buntanetap in Alzheimer’s Disease

Indeterminate GlobeNewswire

Sep. 23, 2026

Tempest Appoints Global Finance Leader Nancy Freda-Smith to Board of Directors

Indeterminate GlobeNewswire